Is chaos in US health policy creating new global opportunities? With major leadership and policy shake-ups the US healthcare ...

Technology has also improved immunisation operations with the use of online appointment scheduling that automates ...

From robot-assisted surgery to personalised disease treatment - technology can do some truly remarkable things. But while the ...

It is the second licensing deal that AbbVie has negotiated this year for a trispecific for multiple myeloma, coming in the ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has cleared the oral neurokinin (NK) 1 and 3 antagonist, under the Lynkuet brand name, for the treatment of moderate to severe vasomotor ...